• Statistician with a biomedical background
  • 10+ years of experience in statistical consultancy


Master of Biomedical sciences (Ghent University)

Master of Statistical data analysis (Ghent University)

Current professional activities

Biostatistician at the Faculty of Medicine and Health Sciences at Ghent University (part-time)

Freelance statistician for a pharmaceutical and for a medical device company.

Previous professional experience

Biostatistician at Innogenetics/Fujirebio
A biotech company developing diagnostic products (Ghent)

Research Associate at Peakadilly/Pronota
An innovative proteomics company (Ghent)


Co-author of around 40 scientific publications including:

  • Declercq, Jozefien et al. “Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial.” The Lancet. Respiratory medicine vol. 9,12 (2021): 1427-1438. (Impact factor 30.7)
  • Vanbutsele, Gaëlle et al. “Effect of early and systematic integration of palliative care in patients with advanced cancer: a randomised controlled trial.” The Lancet. Oncology vol. 19,3 (2018): 394-404. (Impact factor 33.9)
  • Verhelst, Xavier et al. “A Glycomics-Based Test Predicts the Development of Hepatocellular Carcinoma in Cirrhosis.” Clinical cancer research : an official journal of the American Association for Cancer Research vol. 23,11 (2017): 2750-2758. (Impact factor 9.6)